Of 13 women or men without personal history of cancer, 7 (53.8%) were affected by variants of BRCA1 and 6 (46.2%) by variants of BRCA2. On the whole, the majority of BRCA pathogenic variants were reported to be in exon 11 for both genes: 10 (43.5%) variants in exon 11 of BRCA1 and 13 (56.5%) of BRCA2 gene, respectively. This evidence concerns the gene BRCA1 and cancer.